title: Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.
abstract: We examined the effects of 48 h bilateral nephrectomy on plasma and cardiac tissue expression of angiotensin-(1-12) [ANG-(1-12)], ANG I, and ANG II in adult Wistar-Kyoto rats to evaluate functional changes induced by removing renal renin. The goal was to expand the evidence of ANG-(1-12) being an alternate renin-independent, angiotensin-forming substrate. Nephrectomy yielded divergent effects on circulating and cardiac angiotensins. Significant decreases in plasma ANG-(1-12), ANG I, and ANG II levels postnephrectomy accompanied increases in cardiac ANG-(1-12), ANG I, and ANG II concentrations compared with controls. Plasma ANG-(1-12) decreased 34% following nephrectomy, which accompanied 78 and 66% decreases in plasma ANG I and ANG II, respectively (P < 0.05 vs. controls). Contrastingly, cardiac ANG-(1-12) in anephric rats averaged 276 +/- 24 fmol/mg compared with 144 +/- 20 fmol/mg in controls (P < 0.005). Cardiac ANG I and ANG II values were 300 +/- 15 and 62 +/- 7 fmol/mg, respectively, in anephric rats compared with 172 +/- 8 fmol/mg for ANG I and 42 +/- 4 fmol/mg for ANG II in controls (P < 0.001). Quantitative immunofluorescence revealed significant increases in average grayscale density for cardiac tissue angiotensinogen, ANG I, ANG II, and AT(1) receptors of WKY rats postnephrectomy. Faint staining of cardiac renin, unchanged by nephrectomy, was associated with an 80% decrease in cardiac renin mRNA. These changes were accompanied by significant increases in p47(phox), Rac1, and Nox4 isoform expression. In conclusion, ANG-(1-12) may be a functional precursor for angiotensin peptide formation in the absence of circulating renin.
authors.affiliation: The Hypertension and Vascular Research Center, Wake Forest Univ. School of Medicine, Winston-Salem, NC 27157, USA. cferrari@wfubmc.edu
authors.forename: Carlos M
authors.initials: CM
authors.lastname: Ferrario
authors.forename: Jasmina
authors.initials: J
authors.lastname: Varagic
authors.forename: Javad
authors.initials: J
authors.lastname: Habibi
authors.forename: Sayaka
authors.initials: S
authors.lastname: Nagata
authors.forename: Johji
authors.initials: J
authors.lastname: Kato
authors.forename: Mark C
authors.initials: MC
authors.lastname: Chappell
authors.forename: Aaron J
authors.initials: AJ
authors.lastname: Trask
authors.forename: Kazuo
authors.initials: K
authors.lastname: Kitamura
authors.forename: Adam
authors.initials: A
authors.lastname: Whaley-Connell
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
mesh_terms: D000803:Angiotensin I / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000808:Angiotensinogen; D000809:Angiotensins / Q000378:metabolism*; D000818:Animals; D007668:Kidney / Q000378:metabolism / Q000601:surgery; D008297:Male; D023421:Models, Animal; D009206:Myocardium / Q000378:metabolism*; D009392:Nephrectomy; D010446:Peptide Fragments / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011921:Rats, Inbred WKY; D012083:Renin / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000502:physiology
chemical_list: D000809:Angiotensins; D010446:Peptide Fragments; D012333:RNA, Messenger; C515557:proangiotensin-12, rat; D000808:Angiotensinogen; D000804:Angiotensin II; D000803:Angiotensin I; D012083:Renin